Lite Strategy, Inc. Stock Issued During Period, Value, Purchase of Assets
Lite Strategy, Inc. (LITS) reported Stock Issued During Period, Value, Purchase of Assets of $500.00 thousand for the 1-month period ending 2012-08-31, per its 10-Q filed 2017-11-08.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets · last filed 2017-11-08
- 2012-08-31: Stock Issued During Period, Value, Purchase of Assets 1 month $500.00K.
- 2012-08-22: Stock Issued During Period, Value, Purchase of Assets 1 month $500.00K.
- 2012-08-07: Stock Issued During Period, Value, Purchase of Assets $500.00K; Stock Issued During Period, Value, Purchase of Assets 1 month $500.00K.
| Period end | Stock Issued During Period, Value, Purchase of Assets | Stock Issued During Period, Value, Purchase of Assets 1 month |
|---|---|---|
| 2012-08-31 | $500.00K 10-Q · filed 2017-11-08 | |
| 2012-08-22 | $500.00K 10-K · filed 2013-09-18 | |
| 2012-08-07 | $500.00K 10-K · filed 2014-09-09 | $500.00K 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |